Agiliti (NYSE:AGTI) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.09 by 155.56 percent.
vTv Therapeutics Q4 EPS $(0.06), Inline, Sales $9.00K, Same YoY
vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 45.45 percent increase over losses of $(0.11) per share from the same period last year.